Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock
NCT07203833Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Oct 2025
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoints: Vasorin plasma concentration, Correlation between Vasn plasma concentration and noradrenaline dose peak and 6 more. Started Oct 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07203833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07203833.